The conference will include 3 tracks:
Plenary presentations from leaders in the field
Daily Working Group Updates and Discussion Sessions on Precision Medicine for:
Short Oral Presentations (E-posters) with mentored discussions, with focus on early career participants, mentorship and meet-the-professor sessions
Each day of the virtual conference will include a series of plenary talks from key stakeholders and experts in various aspects of precision diabetes medicine, followed by a featured keynote talk from an individual living with diabetes. The Virtual Poster Hall will be open during the entirety of the virtual event to showcase scientific efforts in the field.
Day 1 (8:00-10:00 EST): Vision and Direction of the Precision Medicine for Diabetes Initiative |
Welcome and opening remarks Tracey Brown, CEO, American Diabetes Association |
Opening remarks Stefano Del Prato, President, European Association for the Study of Diabetes |
Keynote: The Precision Medicine in Diabetes Initiative – Treating the Whole Person Robert Gabbay, Chief Scientific and Medical Officer, American Diabetes Association |
Keynote: Real Life Needs of People with Diabetes. Dana Lewis, US, living with type 1 diabetes |
Precision Medicine and the Research Agenda for Diabetes William Cefalu, Director, Division of Diabetes, Endocrinology and Metabolic Disease, NIDDK |
The Precision Medicine in Diabetes Initiative – Vision and Future Direction Paul Franks, Co-Chair, Lund University Diabetes Center, Sweden |
A Vision for Future Diabetes Care based on Precision. Martin Ridderstråle, Senior Vice President and Head of Patient Care, Novo Nordisk Foundation |
Day 2 (9:00-11:30 EST): Clinical and Scientific Challenges and Opportunities for Precision Diabetes Medicine |
Keynote: Personalizing Diabetes Care in 2021 John Buse, Chief, Division of Endocrinology, University of North Carolina at Chapel Hill |
Keynote: Living and staying healthy with type 2 diabetes Adithya Menon, India, living with type 2 diabetes |
Precision Diabetes in South Asians V Mohan, Chair, Dr Mohan’s Diabetes Specialties Centre, Chennai, India |
Sub-classification of diabetes: Possibilities and Challenges. Miriam Udler, Massachusetts General Hospital and Broad Institute, Boston, US |
Precision Approach to Diabetes in Pregnancy Marie-France Hivert, Dept of Population Medicine, Harvard Medical School |
Approach to Precision Medicine for ‘Common’ Type 2 diabetes Chris Rhodes, Chief Scientist, Cardiovascular, Renal and Metabolism, Astra Zeneca, Gaithersburg, MD, US |
Precision Prevention of Type 1 Diabetes Jessica Dunne, Janssen Pharmaceuticals, New Jersey, US |
11:10-11:30 Panel discussion |
Day 3 (9:00-11:20 EST): From History to Future Policy— Broader Context for Precision Diabetes Medicine |
Keynote: Precision Diabetes Care – a historical perspective on race and disease Arleen Tuchman, Nelson O. Tyrone Jr. Professor of History, Vanderbilt University |
Keynote: The Importance of the Diagnosis Kristin Skiados, living with monogenic diabetes |
Precision Monitoring and Technology in Diabetes Care David Klonoff, Director, Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California |
Precision Monitoring – Approach to Policy Implementation Dirk Mueller-Wieland, Head Clinical Research Centre, Dept of Medicine, University of Aachen, Germany |
Public-private partnerships in the research approach to Precision Medicine Bernd Stowasser, Sanofi, IMI Strategic Governance Group, Diabetes & Metabolic Disorders |
The Accelerating Medicines Partnership in Type 2 Diabetes. Philip Smith, Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK |
Thoughts on Precision Medicine in Diabetes: an Industry Perspective. Speaker: Rasmus Rabøl, Corporate Vice President, Clinical Pharmacology and Translational Medicine, Novo Nordisk |
11:10-11:20 Panel discussion, transition to Closing Remarks (11:20-11:30) |